A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19 | MicrobiomeTrials
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19
TERMINATEDPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2020-11-25Est. Completion: 2024-07-22
Enrollment target: 278 participants
Locations
UCSF Fresno, Fresno, California, United States
St. Jude Medical Center/ Providence, Fullerton, California, United States
University of Miami Hospital, Coral Gables, Florida, United States
Baystate Medical Center, Springfield, Massachusetts, United States
Wayne State University, Detroit, Michigan, United States
Providence Portland Medical Center, Portland, Oregon, United States
West Virginia University Medicine Heart & Vascular Institute, Morgantown, West Virginia, United States
University of Alberta Hospital, Edmonton, Alberta, Canada
Vancouver Coastal Health, Vancouver, British Columbia, Canada
Vancouver General Hospital, Vancouver, British Columbia, Canada
William Osler Health System, Brampton, Ontario, Canada